In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.
|Videos|April 9, 2021
Raising Awareness Around Liver Cancer and Disease
Author(s)Kristie L. Kahl
CURE spoke with Dr. Marty T. Sellers and Dr. Laura M. Kulik, on behalf of the Blue Faery, about liver cancer and disease – its treatments, causes and areas outside of therapy.
Advertisement
Advertisement
Related to this article
Lyrfigtu was approved for adults with previously treated cholangiocarcinoma with an FGFR2 gene fusion or other rearrangement.
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatment.
Mindfulness-based cancer recovery and Tai Chi/Qigong improved fatigue and how much pain interfered with daily life among cancer survivors experiencing distress, while Tai Chi/Qigong also improved sleep quality.
A breast cancer survivor reflects on the complicated meaning of pink, remembering what cancer took, those still fighting and the people behind the ribbon.
Paxalisib, first studied in brain cancer, may help HR+ breast tumors respond to CDK4/6 inhibitors again, based on early lab data.
A cancer survivor shares what to say, what not to say and how listening can help support someone through cancer treatment and beyond.
Bravnetsa is the first radioligand therapy approved through the FDA's abbreviated pathway, adding an option for adults with SSTR-positive GEP-NETs.
Advertisement
Advertisement
Trending on CURE
1
Finding the Words: How to Talk to Someone With Cancer
2
Getting Ready to Swim in a Sea of Pink
3
FDA Approves Bravnetsa, an Equivalent to Lutathera, for GEP-NETs
4
Cancer Research Is Looking Beyond the Tumor to Better Understand the Whole Patient
5